Change of name of liposomal medicines at high risk of medication errors

26 September 2019 - Marketing authorisation holders of medicines containing liposomal drug delivery systems are requested to submit a variation ...

Read more →

Names of liposomal medicines to be changed to avoid medication errors

31 July 2019 - All marketing authorisation holders of medicines containing liposomal drug delivery systems are requested to submit to ...

Read more →

Unlicensed and off-label uses of medicines: definitions and clarification of terminology

5 August 2017 - The terms “licensed”, “unlicensed”, and “off-label”, often used in relation to marketing and prescribing medicinal products, ...

Read more →